Voxel S.A. (WSE:VOX)
Poland · Delayed Price · Currency is PLN 119.80
+1.20 (1.01%)
Jul 24, 2026, 5:00 PM CET
Voxel Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | - | 349.92 | 298.62 | 222.03 | 442.66 | 327.64 |
Revenue Growth | - | 17.18% | 34.49% | -49.84% | 35.10% | 54.80% |
Gross Profit Gross Profit Growth | - | 122.01 | 109.29 | 74.77 | 127.66 | 67.6 |
Operating Income Operating Income Growth | - | 101.26 | 98.97 | 63.46 | 98.34 | 50.44 |
Net Income Net Income Growth | 24.27 | 81.36 | 74.66 | 54.9 | 70.55 | 33.96 |
Earnings Per Share EPS Growth | 8.37 | 7.75 | 7.11 | 5.23 | 3.33 | 3.23 |
EPS Growth | 252.15% | 9.00% | 35.95% | 57.06% | 3.10% | 47.49% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Diagnostics - Medical Services and Sales of Radiopharmaceuticals Diagnostics - Medical Services and Sales of Radiopharmaceuticals Growth | 451.79 | 437.63 | 386.77 | 331.98 | 252.78 | 196.21 |
Therapy - Neuroradiosurgery Therapy - Neuroradiosurgery Growth | 15.7 | 15.25 | 13.83 | 11.92 | 10.06 | 9.1 |
IT & Infrastructure - IT Products and Laboratory Equipment IT & Infrastructure - IT Products and Laboratory Equipment Growth | 142.54 | 163.94 | 128.39 | 101.55 | 137.97 | 170.91 |
Exclusions/Unassigned Exclusions/Unassigned Growth | -26.9 | -33.03 | -21.22 | -21.27 | -40.17 | -84.33 |
Total Total Growth | 583.14 | 583.79 | 507.77 | 424.18 | 360.64 | 442.66 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 16.95 | 13.02 | 52.91 | 64.13 | 33.17 | 54.15 |
Total Debt Total Debt Growth | 196.37 | 185.65 | 126.94 | 127.12 | 138.48 | 166.86 |
Net Cash (Debt) Net Cash Growth | -179.42 | -172.62 | -74.03 | -62.99 | -105.31 | -112.72 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -17.08 | -20.01 | -7.05 | -6.00 | -10.03 | -10.73 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | 83.44 | 108.03 | 112.72 | 70.66 | 106.34 | 59.39 |
Capital Expenditures CapEx Growth | -55.1 | -13.21 | -14.4 | -11.8 | -31.67 | -29.93 |
Free Cash Flow Free Cash Flow Growth | 28.34 | 94.83 | 98.32 | 58.85 | 74.67 | 29.47 |
Free Cash Flow Growth | -53.95% | -3.55% | 67.07% | -21.19% | 153.41% | 29.98% |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | - | 34.87% | 36.60% | 33.68% | 28.84% | 20.63% |
Operating Margin | - | 28.94% | 33.14% | 28.58% | 22.22% | 15.40% |
Pretax Margin | - | 28.60% | 30.87% | 29.50% | 20.22% | 13.63% |
Profit Margin | - | 23.25% | 25.00% | 24.72% | 16.20% | 10.41% |
FCF Margin | - | 27.10% | 32.92% | 26.51% | 16.87% | 8.99% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Dividend Per Share Dividend Per Share Growth | 4.780 | 4.780 | 2.780 | 2.170 | 3.000 | 2.000 |
Dividend Per Share Growth | -47.70% | 71.94% | 28.11% | -27.67% | 50.00% | 119.78% |
Dividend Yield | 3.99% | 2.57% | 1.73% | 6.82% | 4.53% | 2.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.85 | - | 16.26 | 11.05 | 8.41 | 13.66 |
Forward PE | 12.93 | 10.87 | 13.73 | 14.80 | 11.95 | 13.06 |
P/FCF Ratio | 28.77 | - | 3.99 | 5.16 | 7.85 | 6.40 |
PS Ratio | 2.16 | - | 1.08 | 1.70 | 2.08 | 1.08 |